Literature DB >> 22521841

Current issues with the immunization program in Japan: can we fill the "vaccine gap"?

Akihiko Saitoh1, Nobuhiko Okabe.   

Abstract

The "vaccine gap" is a term which has been used in Japan to indicate that the current immunization program is behind compared to the programs in other developed countries. The current national immunization program (NIP) which was established under the Japanese Immunization Law includes only six vaccines (eight targeted diseases), and the rest of available vaccines have been categorized as voluntary vaccines, which require out-of-pocket expense in order for the patients to receive them. This has led the vaccination rates for the voluntary vaccines remaining low, and the incidence of the target diseases remaining high. In addition, there are a few domestic rules that exist for immunizations including (1) subcutaneous injection is the standard method of vaccination, (2) the thigh is not considered to be the common site of vaccination in infants, and (3) the intervals of administration of inactivated and live vaccines are strictly determined by law. Along with the "vaccine gap" and the domestic rules, some movements to improve our current NIP are underway; including increased calls to change the NIP from civilians and professionals, the establishment of a group by the representatives from 13 medical professional societies asking the government to consider the immunization policy a "national policy" and seeking the establishment of a new and reorganized national immunization technical advisory group (NITAG). In addition, the Vaccination Subcommittee of Health Sciences Council was formed in the government to reform the current Immunization Law and NIP, which established a new national program for three voluntary vaccines funded by a temporary budget. We hope these new movements will fill the "vaccine gap" and that the NITAG will help ensure that vaccine policy becomes a national policy, and will provide necessary vaccinations without out-of-pocket expense to protect children in Japan from vaccine preventable diseases.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22521841     DOI: 10.1016/j.vaccine.2012.04.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.

Authors:  Tomofumi Nakamura; Mitsuhiro Hamasaki; Hideaki Yoshitomi; Tetsuya Ishibashi; Chiharu Yoshiyama; Eriko Maeda; Nobuyuki Sera; Hiromu Yoshida
Journal:  Appl Environ Microbiol       Date:  2015-01-02       Impact factor: 4.792

Review 2.  A review of factors affecting vaccine preventable disease in Japan.

Authors:  Norimitsu Kuwabara; Michael S L Ching
Journal:  Hawaii J Med Public Health       Date:  2014-12

3.  Close the gap for routine mumps vaccination in Japan.

Authors:  Taito Kitano
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

4.  Mothers' preferences regarding new combination vaccines for their children in Japan, 2014.

Authors:  Aiko Shono; Masahide Kondo
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

5.  Factors associated with seasonal influenza vaccine uptake among children in Japan.

Authors:  Aiko Shono; Masahide Kondo
Journal:  BMC Infect Dis       Date:  2015-02-18       Impact factor: 3.090

6.  Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.

Authors:  Young June Choe; Jae Jeong Yang; Sue K Park; Eun Hwa Choi; Hoan Jong Lee
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

Review 7.  Vaccine chronicle in Japan.

Authors:  Tetsuo Nakayama
Journal:  J Infect Chemother       Date:  2013-07-09       Impact factor: 2.211

8.  Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.

Authors:  Takanori Funaki; Eisuke Inoue; Isao Miyairi
Journal:  BMC Infect Dis       Date:  2016-02-09       Impact factor: 3.090

9.  Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

Authors:  Peter Vink; Masanari Shiramoto; Masayuki Ogawa; Masahiro Eda; Martine Douha; Thomas Heineman; Himal Lal
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

10.  Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications.

Authors:  Hye-Young Kwon; Hyungmin Kim; Brian Godman
Journal:  Front Pharmacol       Date:  2018-09-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.